EPA blocks TNF-α-induced inhibition of sugar uptake in Caco-2 cells via GPR120 and AMPK

J Cell Physiol. 2018 Mar;233(3):2426-2433. doi: 10.1002/jcp.26115. Epub 2017 Aug 30.

Abstract

The aim of the present work was to investigate in Caco-2 cells whether eicosapentaenoic acid (EPA), an omega-3 polyunsaturated fatty acid, could block the inhibitory effect of tumor necrosis factor-α (TNF-α) on sugar transport, and identify the intracellular signaling pathways involved. After pre-incubation of the Caco-2 cells with TNF-α and EPA for 1 hr, EPA prevented the inhibitory effect of the cytokine on α-methyl-d-glucose (αMG) uptake (15 min) and on SGLT1 expression at the brush border membrane, measured by Western blot. The ERK1/2 inhibitor PD98059 and the AMPK activator AICAR also prevented the inhibitory effect of TNF-α on both αMG uptake and SGLT1 expression. Interestingly, the AMPK inhibitor, Compound C, abolished the ability of EPA to prevent TNF-α-induced reduction of sugar uptake and transporter expression. The GPR120 antagonist, AH7614, also blocked the preventive effect of EPA on TNF-α-induced decrease of αMG uptake and AMPK phosphorylation. In summary, TNF-α inhibits αMG uptake by decreasing SGLT1 expression in the brush border membrane through the activation of ERK1/2 pathway. EPA prevents the inhibitory effect of TNF-α through the involvement of GPR120 and AMPK activation.

Keywords: AMPK; EPA; GPR120; SGLT1; TNF-α.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism*
  • Biological Transport
  • Caco-2 Cells
  • Dietary Sugars / metabolism*
  • Eicosapentaenoic Acid / pharmacology*
  • Enzyme Activation
  • Epithelial Cells / drug effects*
  • Epithelial Cells / metabolism
  • Extracellular Signal-Regulated MAP Kinases / metabolism
  • Humans
  • Intestinal Absorption / drug effects*
  • Intestinal Mucosa / drug effects*
  • Intestinal Mucosa / metabolism
  • Methylglucosides / metabolism*
  • Receptors, G-Protein-Coupled / metabolism*
  • Signal Transduction
  • Sodium-Glucose Transporter 1 / antagonists & inhibitors*
  • Sodium-Glucose Transporter 1 / metabolism
  • Tumor Necrosis Factor-alpha / pharmacology*

Substances

  • Dietary Sugars
  • FFAR4 protein, human
  • Methylglucosides
  • Receptors, G-Protein-Coupled
  • SLC5A1 protein, human
  • Sodium-Glucose Transporter 1
  • Tumor Necrosis Factor-alpha
  • methylglucoside
  • Eicosapentaenoic Acid
  • Extracellular Signal-Regulated MAP Kinases
  • AMP-Activated Protein Kinases